Sulfadiazine and Swallowing difficulty - a phase IV clinical study of FDA data

Summary:

Swallowing difficulty is reported as a side effect among people who take Sulfadiazine (sulfadiazine), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Bactrim, and have Hiv infection.

The phase IV clinical study analyzes which people have Swallowing difficulty when taking Sulfadiazine. It is created by eHealthMe based on reports of 2,214 people who have side effects when taking Sulfadiazine from the FDA, and is updated regularly.

What is Sulfadiazine?

Sulfadiazine has active ingredients of sulfadiazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 2,265 Sulfadiazine users. Check the latest studies of Sulfadiazine.

What is Swallowing difficulty?

Swallowing difficulty is found to be associated with 2,402 drugs and 3,352 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.

On Jul, 27, 2026

2,214 people reported to have side effects when taking Sulfadiazine.
Among them, 19 people (0.86%) have Swallowing difficulty.

Could Sulfadiazine cause Swallowing difficulty?

Among these 19 people:

How long have people been on Sulfadiazine when they have Swallowing difficulty? *

What is the gender of people who have Swallowing difficulty when taking Sulfadiazine? *

female: 52.63 %
male: 47.37 %

What is the age of people who have Swallowing difficulty when taking Sulfadiazine? *

What are other drugs people take besides Sulfadiazine? *

What are other side effects people have besides Swallowing difficulty? *

Cerebral Toxoplasmosis (parasitic disease of brain caused by the protozoan toxoplasma gondii): 8 people, 42.11%
Fever: 5 people, 26.32%
Weight Decreased: 4 people, 21.05%
Gait Disturbance: 4 people, 21.05%
General Physical Health Deterioration (weak health status): 4 people, 21.05%
Leukopenia (less number of white blood cells in blood): 4 people, 21.05%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 21.05%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 21.05%
Thrombocytopenia (decrease of platelets in blood): 4 people, 21.05%
Anaemia (lack of blood): 4 people, 21.05%

What are the existing conditions these people have? *

Hiv Infection: 7 people, 36.84%
Cerebral Toxoplasmosis (parasitic disease of brain caused by the protozoan toxoplasma gondii): 5 people, 26.32%
Toxoplasmosis (a parasitic disease caused by the protozoan toxoplasma gondii): 3 people, 15.79%
Oesophageal Candidiasis (fungal infection of oesophagus): 2 people, 10.53%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 10.53%
Epstein-Barr Virus Infection: 2 people, 10.53%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 5.26%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 1 person, 5.26%
Cytomegalovirus Infection: 1 person, 5.26%
Enterobacter Infection (infection caused by bacteria of the family enterobacteriaceae): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Sulfadiazine and have Swallowing difficulty?

- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sulfadiazine:

Sulfadiazine (2,265 reports)

Browse all side effects of Sulfadiazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing difficulty:

Swallowing difficulty (2,402 drugs)

Browse all the conditions that are associated with Swallowing difficulty:

Swallowing difficulty (3,352 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sulfadiazine (the active ingredients of Sulfadiazine) and Sulfadiazine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.